# 21586-211-02 · Ifosfamide Injection · SteriMax, Inc. — FDA drug shortage duration tracker

For 21586-211-02 · Ifosfamide Injection · SteriMax, Inc., package ndc is 21586-211-02; generic name is Ifosfamide Injection; manufacturer is SteriMax, Inc; status is Current; availability now is Available, recorded from its source on 2026-09-10.

- **Package NDC:** 21586-211-02 _(verified: appears in the quote below)_
- **Generic name:** Ifosfamide Injection _(verified: appears in the quote below)_
- **Manufacturer:** SteriMax, Inc. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **FDA note:** To place an order, please contact GlobalRX at info@globalrx.com or (919) 245-8418 _(verified: appears in the quote below)_
- **Initial posting date:** 06/12/2026 _(verified: appears in the quote below)_
- **Last update date:** 09/08/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 90 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Oncology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "06/12/2026", "package_ndc": "21586-211-02", "generic_name": "Ifosfamide Injection", "related_info_link": "https://www.fda.gov/media/194567/download", "contact_info": "877-373-4657", "availability": "Available", "related_info": "To place an order, please contact GlobalRX at info@globalrx.com or (919) 245-8418"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "09/08/2026", "therapeutic_category": [ "Oncology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02)", "company_name": "SteriMax, Inc.", "status": "Current"

### Status

> "update_date": "09/08/2026", "therapeutic_category": [ "Oncology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02)", "company_name": "SteriMax, Inc.", "status": "Current"

### Last update date

> "update_date": "09/08/2026", "therapeutic_category": [ "Oncology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02)", "company_name": "SteriMax, Inc.", "status": "Current"

### Dosage form

> "update_date": "09/08/2026", "therapeutic_category": [ "Oncology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02)", "company_name": "SteriMax, Inc.", "status": "Current"

### Therapeutic category

> "update_date": "09/08/2026", "therapeutic_category": [ "Oncology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02)", "company_name": "SteriMax, Inc.", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-10. Review by: 2026-09-13.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).